On March 19th, a research team from the University of Texas reported in the recent issue of Science Advances that monkeys infected with Ebola virus can be cured through oral medication. This has opened up new avenues for humans to obtain more practical and economical treatment methods. In this experiment, the research team used the antiviral drug Obeldesvir. This is the oral version of remdesivir originally developed for the treatment of COVID-19 infection. Obedesivir is a “polymerase inhibitor” that works by blocking key enzymes required for virus replication.
Scan code to share